Study on inflammation markers in obesity
Part of Hormones & metabolism clinical trials.
This trial examines how two blood markers, SII and SIRI, relate to health issues linked to obesity. It aims to help doctors better predict and manage conditions like metabolic problems in overweight and obese adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are overweight (BMI 25–29.9) or have obesity (BMI 30 or higher)
- You can attend scheduled visits at the study center
- You are willing to sign a consent form
- You are not pregnant, breastfeeding, or taking immune-suppressing drugs
- You do not have an active infection, inflammatory disease, cancer, or recent major surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how your body's daily habits and subtle inflammation may affect your risk for heart disease and related conditions. You'll use a mobile app to log your food intake and help researchers understand individual factors that influence low-grade inflammation.
This study looks at how inflammation affects heart disease and diabetes. It may help find new ways to prevent or treat these conditions.
This study examines how your body naturally resolves inflammation, which is important for heart health and conditions like diabetes. It involves blood draws and tests to understand how inflammation works.
This study looks at how starting a structured exercise program affects inflammation in the body. Researchers want to understand the link between physical activity and inflammation markers in healthy young adults.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.